Shawnte Mitchell - 03 Mar 2026 Form 4 Insider Report for Olema Pharmaceuticals, Inc. (OLMA)

Reporting relationship: CHIEF LEGAL OFFICER
Issuer ticker: OLMA
Reported as of: 03 Mar 2026
Net transaction value: -$951,503
SEC form: 4
Accepted by SEC: 05 Mar 2026, 20:00:07 UTC
Prior SEC filing: 04 Feb 2026
Source filing: View source filing
Reporting owner signature: /s/ Shawnte Mitchell

Key filing fact

Shawnte Mitchell filed Form 4 for Olema Pharmaceuticals, Inc. (OLMA) on 05 Mar 2026.

Key facts

This page summarizes Shawnte Mitchell's Form 4 filing for Olema Pharmaceuticals, Inc. (OLMA).
7 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 05 Mar 2026, 20:00.

Change

Previous filing in this sequence was filed on 04 Feb 2026.
Current net transaction value: -$951,503.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001749432 Primary reporting owner

Mitchell Shawnte

Relationship: CHIEF LEGAL OFFICER
Address: C/O OLEMA PHARMACEUTICALS, INC., 780 BRANNAN ST, SAN FRANCISCO
Signature: /s/ Shawnte Mitchell
Signature date: 05 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

OLMA transaction

Common Stock

Options Exercise

Transaction value
Shares: +15,000
Change %
Price: $4.37^*
Shares after: 15,000
Date: 03 Mar 2026
Ownership: Direct

OLMA transaction

Common Stock

Sale

Transaction value: $345,150
Shares: -15,000
Change %: -100%
Price: $23.01
Shares after: 0
Date: 03 Mar 2026
Ownership: Direct
Footnotes: F1

OLMA transaction

Common Stock

Options Exercise

Transaction value
Shares: +25,000
Change %
Price: $4.37^*
Shares after: 25,000
Date: 04 Mar 2026
Ownership: Direct

OLMA transaction

Common Stock

Sale

Transaction value: $600,600
Shares: -24,767
Change %: -99%
Price: $24.25
Shares after: 233
Date: 04 Mar 2026
Ownership: Direct
Footnotes: F2

OLMA transaction

Comon Stock

Sale

Transaction value: $5,753
Shares: -233
Change %: -100%
Price: $24.69
Shares after: 0
Date: 04 Mar 2026
Ownership: Direct
Footnotes: F3

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

OLMA transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value
Shares: -15,000
Change %: -3.3%
Price: $0.000000^*
Shares after: 435,000
Date: 03 Mar 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 15,000
Exercise price: $4.37
Footnotes: F4

OLMA transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value
Shares: -25,000
Change %: -5.7%
Price: $0.000000^*
Shares after: 410,000
Date: 04 Mar 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 25,000
Exercise price: $4.37
Footnotes: F4

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

The weighted average sale price for the transaction reported was $23.01, and the range of prices were between $22.89 and $23.19. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided.

Footnote F2

The weighted average sale price for the transaction reported was $24.25, and the range of prices were between $23.68 and $24.64. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided.

Footnote F3

The weighted average sale price for the transaction reported was $24.69, and the range of prices were between $24.68 and $24.70. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided.

Footnote F4

25% of the shares subject to the option vest on February 28, 2026 and 1/48 of the total number of shares subject to the option vest each month thereafter, subject to the Reporting Person's continuous service through each applicable vesting date.